These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 25763772

  • 1. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M, Hubert D, Burgel PR, Génin E, Honoré I, Martinez B, Gaitch N, Chapron J, Kanaan R, Dusser D, Girodon E, Bienvenu T.
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [Abstract] [Full Text] [Related]

  • 2. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E, Aviram M, Yahav Y, Rivlin J, Blau H, Bentur L, Avital A, Villa Y, Schwartz S, Kerem B, Kerem E.
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Emond MJ, Louie T, Emerson J, Chong JX, Mathias RA, Knowles MR, Rieder MJ, Tabor HK, Nickerson DA, Barnes KC, NHLBI GO Exome Sequencing Project, Go L, Gibson RL, Bamshad MJ.
    PLoS Genet; 2015 Jun; 11(6):e1005273. PubMed ID: 26047157
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL, Mayer-Hamblett N, Burns JL, Khan U, Baines A, Ramsey BW, Rowe SM, GOAL (the G551D Observation-AL) Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network.
    Clin Infect Dis; 2015 Mar 01; 60(5):703-12. PubMed ID: 25425629
    [Abstract] [Full Text] [Related]

  • 10. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V, Arduino C, Cappello N, Piana R, Salmin P, Bardessono M, Goia M, Padoan R, Bignamini E, Costantini D, Pizzamiglio G, Bennato V, Colombo C, Giunta A, Piazza A.
    Eur J Hum Genet; 2005 Jan 01; 13(1):96-101. PubMed ID: 15367919
    [Abstract] [Full Text] [Related]

  • 11. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
    Kubesch P, Dörk T, Wulbrand U, Kälin N, Neumann T, Wulf B, Geerlings H, Weissbrodt H, von der Hardt H, Tümmler B.
    Lancet; 1993 Jan 23; 341(8839):189-93. PubMed ID: 7678316
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N, Mekus F, Bronsveld I, Bijman J, Veeze HJ, von der Hardt H, Tummler B, Ballmann M.
    Pediatr Res; 2004 Jan 23; 55(1):69-75. PubMed ID: 14605249
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
    Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I.
    Am J Respir Crit Care Med; 2010 May 15; 181(10):1078-84. PubMed ID: 20167849
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB.
    Infect Immun; 1999 Sep 15; 67(9):4744-50. PubMed ID: 10456926
    [Abstract] [Full Text] [Related]

  • 19. Is infection with hypermutable Pseudomonas aeruginosa clinically significant?
    Auerbach A, Kerem E, Assous MV, Picard E, Bar-Meir M.
    J Cyst Fibros; 2015 May 15; 14(3):347-52. PubMed ID: 25308183
    [Abstract] [Full Text] [Related]

  • 20. The determinants of survival among adults with cystic fibrosis-a cohort study.
    Durda-Masny M, Goździk-Spychalska J, John A, Czaiński W, Stróżewska W, Pawłowska N, Wlizło J, Batura-Gabryel H, Szwed A.
    J Physiol Anthropol; 2021 Nov 08; 40(1):19. PubMed ID: 34749804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.